Deberdt R
Acta Psychiatr Belg. 1976 Jan-Feb;76(1):157-66.
Pipamperone solution or tablets were prescribed for four weeks to 188 patients (3-100 years) with behavior disorders. Fifty of these (group A) were mental retardates, the remaining 138 (group B) had a normal I.Q. Their doses were gradually increased until optimal effect was reached. Nearly all 17 items of a behaviour rating scale had improved very significantly by the end of the fourth week, while in 82% of the patients of group A and 76% of group B results were rated good to very good. Also, pipamperone proved to be far superior to previous psychotropic drugs in patients who had been treated before.
哌泊塞嗪溶液或片剂被开给188名（3至100岁）患有行为障碍的患者服用四周。其中50名（A组）是智力迟钝者，其余138名（B组）智商正常。他们的剂量逐渐增加，直至达到最佳效果。到第四周结束时，行为评定量表的几乎所有17项指标都有非常显著的改善，而A组82%的患者和B组76%的患者结果被评为良好至非常好。此外，在之前接受过治疗的患者中，哌泊塞嗪被证明远比之前的精神药物优越。
